According to the new market research report Cardiac Monitoring Devices Market
Size is projected to reach USD 26.8 billion by 2025 from USD 22.1
billion in 2020, at a CAGR of 4.0% from 2020 to 2025. The growth of this
market is driven by the increasing prevalence of cardiovascular
diseases; availability of reimbursement for CM CRM devices; launch of
innovative products by market players; increasing investments, funds,
and grants for research on CM CRM devices; and the growing preference
for wearable cardiac devices.
Browse and in-depth TOC on “Cardiac Monitoring Devices Market”
336 – Tables
40 – Figures
266 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=55
“ECG Devices is expected to hold the largest share of the Cardiac Monitoring Devices Market Share in 2020”
On
the basis of cardiac monitoring devices by type, the market is
segmented into ECG devices, event monitors, implantable loop recorders
(ILRs), cardiac output monitoring (COM) devices, mobile cardiac
telemetry (MCT) devices, and smart ECG monitors. In 2019, the ECG
devices segment accounted for the largest share of the market. The large
share of this segment can be attributed to technological advancements
such as the incorporation of advanced algorithms and workflow
improvement features, such as simplified operations, touchscreen
systems, portability, wireless features, and better connectivity with
cardiovascular information systems (CVIS), electronic medical records
(EMRs), and ECG management systems.
OPPORTUNITY: Measures to reduce infections caused due to CIEDs
CIEDs are associated with an increase in survival and quality of life while treating cardiac arrhythmias. However, CIED-associated infections are a major complication associated with the use of these devices. CIED infections most commonly occur in patients with an implantable cardioverter defibrillator device or cardiac resynchronization therapy defibrillator device. According to the European Heart Journal, the incidence of CIED infections was 1.19% for pacemakers, 1.91% for implantable cardioverter-defibrillators, 2.18% for cardiac resynchronization therapy pacemakers (CRT-Ps), and 3.35% for CRT defibrillators (CRTDs).
Medtronic offers an absorbable, multifilament mesh envelope (TYRX Absorbable Antibacterial Envelope) to improve CIED stabilization in the subcutaneous pocket and to elute the antibiotics minocycline and rifampin. These envelopes are designed for use with cardiac implantable electronic devices (CIEDs), such as implantable cardioverter defibrillators (ICDs) and pacemakers. In 2019, results of an international randomized controlled trial showed that the envelope reduced the incidence of infection by 40%, compared to standard-of-care infection prevention alone.
“North America commanded the largest share of the Cardiac Monitoring Devices Market Trend in 2020.”
On
the basis of region, the Cardiac Rhythm Management Devices Market is
segmented into North America, Europe, Asia Pacific, and Rest of the
World. In 2019, North America commanded the largest share of the market.
The large share of this market segment can be attributed to the
increasing incidence of CVD, increasing healthcare expenditure, growing
disposable income, growing healthcare awareness, and the availability of
technologically advanced devices in the region.
Request For Free Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=55
The major players operating in this Cardiac Monitoring Market
are Medtronic (Ireland), Boston Scientific (US), Abbott Laboratories
(US), GE Healthcare (US), BIOTRONIK (Germany), and Koninklijke Philips
(Netherlands), Asahi Kasei Corporation (Japan), MicroPort Scientific
Corporation (China), Hill-Rom Holdings (US), Nihon Kohden (Japan),
SCHILLER AG (Switzerland), BioTelemetry (US), BPL Medical Technologies
(India), ACS Diagnostics (US), Shenzhen Mindray Bio-Medical Electronics
(China), Lepu Medical Technology (China), Shree Pacetronix (India),
OSYPKA (Germany), and BTL t(US), Alivecor, Inc. (US), Amiitalia (Italy),
Bexen Cardio (Spain), Narang Medical Limited (India), MeTrax GmbH
(Germany), and Progetti Srl (Italy).
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Related Reports:
https://www.marketsandmarkets.com/Market-Reports/Diagnostic-ECG-global-Market-173.html
https://www.marketsandmarkets.com/Market-Reports/cardiac-resynchronization-therapy-market-194506584.html
https://www.marketsandmarkets.com/Market-Reports/automated-external-defibrillator-market-549.html
